Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06938061 · ClinicalTrials.gov registry record
Utilizing 3D Imaging for Burn Wound Assessment
A clinical trial of Burn and 2nd Degree Burn of the Skin, sponsored by HealthPartners Institute.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT06938061: Recruiting study of Burn and 2nd Degree Burn of the Skin, sponsored by HealthPartners Institute.
NCT06938061 is a study of Burn and 2nd Degree Burn of the Skin that is actively recruiting participants, run by HealthPartners Institute. The registered enrollment target is 75 participants, above the 44-participant average among 8 other Burn trials with a reported enrollment target (70% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06938061, a study of Burn and 2nd Degree Burn of the Skin, is actively recruiting participants, sponsored by HealthPartners Institute.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this prospective cohort study is to determine if the DermaMonitor camera can accurately determine burn size in patients with 1st, 2nd, or 3rd degree burns, with exploratory aim of testing a new Artificial Intelligence (AI) program for determining burn depth. The main aims are: 1. The primary aim of this study is to assess an objective process for the classification of burn size using the DermaMonitor wound camera. 2. An exploratory aim of this study is to begin to train an Artificial Intelligence (AI) program to classify burn depth (1st, 2nd, 3rd degree) using the 3D images from this novel wound camera. Researchers will compare DermaMonitor size classification and AI depth classification to clinician determinations. Participants will have images taken of their burn. Participation ends when the images are taken.
Primary Outcome
Measurements of the burn will be taken by clinicians in the burn clinic and translated into total burn surface area (TBSA) using body mass index and height. This will be compared to TBSA computed from measurements taken virtually using the DermaMonitor camera and the same body mass index and height values.
Conditions Studied
Interventions
- DEVICE 3D Imaging
Study Locations (1)
Minnesota
- Regions Hospital Burn Clinic - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2026-06 |
What NCT06938061 shows while recruiting
NCT06938061 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, above the 44-participant average among 8 other Burn trials with a reported enrollment target (70% higher).
The record links to 4 conditions, with Burn appearing as the primary indexed condition, and to 1 intervention - of which 3D Imaging is the first listed.
NCT06938061 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06938061 about?
NCT06938061 is a clinical study titled "Utilizing 3D Imaging for Burn Wound Assessment". The goal of this prospective cohort study is to determine if the DermaMonitor camera can accurately determine burn size in patients with 1st, 2nd, or 3rd degree burns, with exploratory aim of testing a new Artificial Intelligence (AI) program for determining burn depth. The main aims are: 1. The pr...
What is the current status of trial NCT06938061?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2025-05-20. Estimated completion is 2026-06.
What conditions does trial NCT06938061 study?
This clinical trial studies the following conditions: Burn, 2nd Degree Burn of the Skin, 3rd Degree Burn of the Skin, 1st Degree Burn of the Skin.
What interventions are being tested in trial NCT06938061?
The interventions under investigation include: 3D Imaging (DEVICE).
Who is sponsoring clinical trial NCT06938061?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06938061 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06938061's enrollment target sits among peer trials
75 2nd of 8 the highest of 8 other Burn trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Burn trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA
RECRUITING
-
Paraffin Wax and Exercise Prospective
RECRUITING · NA
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thickness Wounds
ACTIVE NOT RECRUITING · NA
-
A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI